Boulder Ventures

Life Sciences

	ARCA biopharma Business: Drug discovery based on pharmacogenomics of heart disease. Co-investors: Atlas Ventures; Pequot Ventures


	Array Biopharma Business: Array is a discovery research organization that sells chemicals and services to the pharmaceutical industry. Update: IPO November 2000 (NASDAQ:ARRY) Co-investors: Falcon Technology Ventures; Frazier & Co.; ARCH Ventures; Advent International; Mitsui & Co. USA


	Barofold Business: Barofold will commercialize patented technology that will dramatically improve the cost of purity and manufacturing protein molecules. Co-investors: HBM Partners


	Dharmacon Business: Leading supplier worldwide of synthetic RNA Update: Sold to Fisher Scientific March 2004 (NYSE:FSH) Co-investors: Telegraph Hill Partners


	Entelos, Inc. Business: Entelos software and services offer decision-support and disease knowledge management for biopharmaceutical researchers. Co-investors: Abingworth Management; Charles River Partners; St. Paul Venture Partners Update: IPO on London AIM 4/06


	Genomica Business: Genomica's database software, Discovery Manager, allows researchers to organize and analyze genetic sequences for drug discovery. Update: IPO (NASDAQ:GNOM); Sold to Exelixis, November, 2001 Co-investors: Falcon Technology Partners; ARCH Venture Partners; INVESCO Trust Company; The Kaufmann Fund


	Millennium Pharmacy Systems, Inc. Business: Millennium Pharmacy Systems offers technology-enabled institutional pharmacy services. Co-investors: CHL Medical Partners


	Hiberna Corporation Business: Drug development based on novel model organisms that exhibit profound biology. Co-investors: Peierls Foundation


	MiRagen Therapeutics Business: MicroRNA applications in cardiovascular disease. Co-investors: Atlas Venture

BACK TO TOP

Colorado
T: 303-444-6950 F: 303-444-0267

Maryland
T: 410-998-3114 F: 410-356-5492

site by sazas design